Roumell Asset Management, LLC

Roumell Asset Management, LLC has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Paratek Pharmaceuticals, Inc., Tecumseh Products Co and Putnam Managed High Yield Trust. The record holds 76 filings, for trades running from 24 February 2006 to 13 December 2013.

Market trades split into 12 purchases (€1.1M) and 44 sales (€649k). Netting one side against the other leaves €465k of net buying. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2013 to date brings no purchases and 44 sales.

Half of the purchases are above €77k and half below.

The newest entry dates from 17 December 2013: an open-market sale of €3,784, in Paratek Pharmaceuticals, Inc. The last insider purchase was made public on 15 March 2006, 7,528 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.